FDA Inspection 1198323 — Patheon Inc.

Patheon Inc. — FEI 3000264888

The FDA completed an inspection of Patheon Inc. on February 24, 2023 in Mississauga. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 24, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Mississauga (Canada)

Citations

IDCFRDescription
440221 CFR 211.192Written record of investigation incomplete